Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Hypertension. 2019 Feb;73(2):335–341. doi: 10.1161/HYPERTENSIONAHA.118.12225

Table 1.

Baseline characteristics in the six study cohorts

YFS
(N=2,554)
BHS
(N=1,300)
CDAH
(N=695)
Muscatine
(N=721)
Insulin
(N=294)
Kaunas
(N=361)
All
(N=5,925)
Variable Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD P-value

Age (years) 11±4 10±3 13±2 13±3 14±2 13±0.3 <0.0001 12±4
Sex (male %) 54 57 54 52 47 54 0.44 54
Systolic blood pressure (mmHg) 112±11 100±10 109±13 115±14 108±9 114±12 <0.0001 109±13
Diastolic IV blood pressure (mmHg) 75±10 62±8 78±12 75±9.3 - - <0.0001 72±11
Diastolic V blood pressure (mmHg) 68±10 45±12 66±12 68±10 56±13 55±11 <0.0001 62±15
Mean arterial pressure-IV (mmHg) 88±9 75±8 81±10 89±10 - - <0.0001
Mean arterial pressure-V (mmHg) 83±9 63±10 81±10 83±10 73±10 75±9 <0.0001 76±12
Pulse pressure-IV (mmHg) 38±11 55±13 43±13 40±11 - - 0.0003
Pulse pressure-V (mmHg) 45±11 54±13 42±13 48±13 51±13 59±14 <0.0001 48±13
Body mass index (kg/m2) 17.8±3.0 17.7±3.6 18.6±2.9 19.8±3.5 22.7±5.1 18.9±3.1 <0.0001 18.4±3.6
*

In the Insulin- and Kaunas studies diastolic IV blood pressure was not measured.

Group comparisons among study cohorts